News

SCM organised The 6th International Summit on Innovative Drug Discovery on campus on 26 October. The Summit gathered a group of distinguished scholars and pioneers from the fields of drug discovery and the pharmaceutical industry, discussing the trends and challenges of innovative drug development, and sharing personal experience of their translational research in drug discovery.

Professor Alexander Wai, President and Vice-Chancellor of HKBU, and Professor Lyu Aiping, Vice-President (Research and Development) cum Acting Dean of Chinese Medicine officiated at the Opening Ceremony.

In his welcoming address, Professor Wai said, “The University has been striving to the promotion of innovative research and translation of research outcome and the commitment to the offering of better health solutions for the society”. He also shared the latest developments of the University’s Chinese medicine research teams in the areas of new drug discovery and clinical trials.

Speaking at the Ceremony, Professor Lyu acknowledged the valuable contribution of Chinese medicine to modern new drug innovation and pointed out the importance of transdisciplinary collaboration. He stressed that drug discovery involves various disciplines, including pharmacology, chemistry, biology, clinical medicine, and artificial intelligence, in which transdisciplinary collaboration is essential in accelerating future medical development.

The Summit attracted over 400 attendees participating in person and online, including researchers, scholars, potential investors, industry experts, Chinese medicine practitioners, and members of the SCM community. It served as an important platform for academic exchange and transdisciplinary collaboration for the advancement of new drug development.